SOPHARMA AD - Notification_BRIZ_03122013 ENG

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 150 / 2013

Date of issue: 2013-12-03

Short name of the issuer

SOPHARMA AD

Subject

Notification_BRIZ_03122013 ENG

Official market - legal basis

Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne

Unofficial market - legal basis

Contents of the report:

Sopharma AD (the “Company") notifies that it has invested in the capital increase of its subsidiary Briz (Riga , Latvia ) in order to expand its presence on the markets of the three Baltic States and Belarus. The shares of Sopharma AD in the capital of the company after the increase reached 66.14% (previously 51%). The expansion of the presence on the market of the Republic of Belarus includes acquisition of a warehouse complex, implementation of an integrated information system as well as the acquisition of new pharmacies. In 2013 Briz increased the total number of its pharmacies to 91 through the acquisition of three pharmacy chains in the Republic of Belarus. It also completed the acquisition of a company for wholesale of pharmaceutical products. As a result of these activities the consolidated revenues of Briz since the beginning of 2013 have almost doubled compared to revenues for the same period of 2012 and amount to over 33 million EUR.

Annexes

File Description

Notification_BRIZ_03122013 ENG.doc Notification_BRIZ_03122013 ENG

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2013-12-03 Ognian Donev Executive Director